Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Menu
Open search dialog Magnifying Glass My UK HealthCare

Natasha Kyprianou, PhD, MBBS

James F. Hardymon Chair in Urology Research
Why are there no ratings?
natasha kyprianou

  • About

    Faculty Rank

    Professor
Are you happy with the care you received from this provider?

Please let us know by filling out a patient satisfaction survey when you get one. You can also leave an online review by clicking the button below.

Leave a review

  • Publications

    1. Doxazosin induces apoptosis of benign and malignant prostate epithelial cells via a death receptor mediated pathway. Garrison JB and Kyprianou N. Cancer Res 66:464-472, 2006.
    2. Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity Garrison JB, Shaw Y-J, Chen C-S and Kyprianou N. Cancer Res 67(23):11344-11352, 2007.
    3. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Sakamoto S, McCann RO, Dhir R and Kyprianou N. Cancer Res 70(5):1885-1895, 2010.
    4. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. Zhu M and Kyprianou N. The FASEB Journal 24(3):769-777, 2010.
    5. Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Zhu M, Horbinski C, Garzotto M, Qian D, Beer T and Kyprianou N. Cancer Res 70(20):7992-8002, 2010.

  • Research

    Cancer Center Member

    Research Focus

    Prostate cancer.

    Programs

    • Cancer Cell Biology and Signaling

    College & Department

    • College of Medicine
    • Department of Surgery

    For Referring Physicians

    306 Combs Research Building
    800 Rose Street, University of Kentucky
    Lexington, KY 40536
    United States

    Phone
    859-323-9812